These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1891883)

  • 21. [Venezuelan equine encephalitis: state-of-the-art].
    Anishchenko M; Alekseev VV; Lipnitskiĭ AV
    Vopr Virusol; 2006; 51(6):10-3. PubMed ID: 17214075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venezuelan equine encephalomyelitis: antibody response in vaccinated horses and resistance to infection with virulent virus.
    Jochim MM; Barber TL; Luedke AJ
    J Am Vet Med Assoc; 1973 Feb; 162(4):280-3. PubMed ID: 4686185
    [No Abstract]   [Full Text] [Related]  

  • 23. [The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers].
    Petrov AA; Plekhanova TM; Sidorova ON; Borisevich SV; Makhlay AA
    Vopr Virusol; 2015; 60(3):14-8. PubMed ID: 26281301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virulence of Venezuelan equine encephalomyelitis virus subtypes for various laboratory hosts.
    Calisher CH; Maness KC
    Appl Microbiol; 1974 Nov; 28(5):881-4. PubMed ID: 4155263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venezuelan equine encephalitis.
    Johnson KM; Martin DH
    Adv Vet Sci Comp Med; 1974; 18(0):79-116. PubMed ID: 4609399
    [No Abstract]   [Full Text] [Related]  

  • 28. [The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus].
    Lukin EP; Chernikova NK
    Vopr Virusol; 1993; 38(2):71-4. PubMed ID: 8059525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenicity of a Venezuelan equine encephalomyelitis serotype IE virus isolate for ponies.
    Sahu SP; Pedersen DD; Jenny AL; Schmitt BJ; Alstad AD
    Am J Trop Med Hyg; 2003 Apr; 68(4):485-94. PubMed ID: 12875302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of back passage of Venezuelan equine encephalomyelitis vaccine (TC-83) on the central nervous system of horses.
    Monlux WS; Luedke AJ; Mercado S; Rosales JC; Rios R
    J Am Vet Med Assoc; 1972 Oct; 161(7):832-3. PubMed ID: 4669261
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenesis of Venezuelan equine encephalitis.
    Taylor KG; Paessler S
    Vet Microbiol; 2013 Nov; 167(1-2):145-50. PubMed ID: 23968890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
    Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
    Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular clearance of venezuelan equine encephalomyelitis viruses as a correlate to virulence for rhesus monkeys.
    Jahrling PB; Hilmas DE; Heard CD
    Arch Virol; 1977; 55(1-2):161-4. PubMed ID: 411457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).
    Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B
    J Virol Methods; 2010 Feb; 163(2):424-32. PubMed ID: 19903494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
    Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
    Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The course of airborne infection in rabbits infected with the Venezuelan encephalomyelitis virus].
    Sergeev AN; Ryzhikov AB; Bulychev LE; Stepkina EO; Tkacheva NV
    Vopr Virusol; 1991; 36(6):492-5. PubMed ID: 1785185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
    Elvin SJ; Bennett AM; Phillpotts RJ
    J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of mutations in genes of Venezuelan equine encephalomyelitis virus structural proteins on its attenuation].
    Frolov IV; Agapov EV; Kolykhalov AA; Netesov SV; Sandakhchiev LS
    Dokl Akad Nauk; 1992; 326(6):1078-82. PubMed ID: 1490193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.